stella
beta
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors — Stella
Recruiting
Back to Refractory and/or Relapsed Metastatic Solid Tumors trials
Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations
(3 sites)
United States
The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland
Albert Einstein College of Medicine, Children's Hospital at Montefiore, The Bronx, New York
New York Medical Center/ Maria Fareri Children's Hospital, Valhalla, New York
View full record on ClinicalTrials.gov